Clinical Inquiries

Is megestrol acetate safe and effective for malnourished nursing home residents?

Author and Disclosure Information

 

References

...And some lose weight

In a 2005 prospective case series of 17 nursing home residents (mean age 92 years [standard deviation, 6], 88% women), MA (400 mg/d for 63 days) was associated with weight loss (mean=-2.13±9.32 lb).6 Nine patients (53%) lost weight (mean=9.3±5.4 lb), and 8 patients (47%) gained weight (mean=5.9±4.9 lb).

A retrospective chart review in 2000 of 14 nursing home residents (mean age 84 years, range 74 to 97 years; 85% women) who received MA 40 to 800 mg/d for one to 15 weeks showed that 43% gained weight (mean=3.1 kg), 43% lost weight (mean=2.0 kg), and 14% had no weight change.7

A 2002 retrospective chart review of 50 nursing home residents (mean age 79 years, range 31 to 93 years; 74% women) who were treated with MA 200 to 2400 mg/d for at least 6 months found a mean weight loss of 1.1 to 2.2 kg.8 In the 6 months after MA discontinuation, weight gain for available subjects (5 to 16 patients) varied (mean monthly change=-0.17 kg to 3.07 kg). The study had a high attrition rate (26 patients were lost 6 months after MA initiation; 39 were lost 6 months after MA discontinuation).

RECOMMENDATIONS

The 2015 American Geriatrics Society Beers Criteria for potentially inappropriate medication use in older adults strongly advises against the use of MA because of limited increases in weight and increased risk of thrombotic events.9

Pages

Evidence-based answers from the Family Physicians Inquiries Network

Recommended Reading

Up to 47 million Americans may have “preclinical” Alzheimer’s disease, study estimates
MDedge Family Medicine
Head injury linked to amyloid deposition decades later
MDedge Family Medicine
Loneliness is common, and not just in the elderly
MDedge Family Medicine
Tau imaging predicts looming cognitive decline in cognitively normal elderly
MDedge Family Medicine
Idalopirdine falls short in three phase 3 Alzheimer’s trials
MDedge Family Medicine
Novel herpes zoster vaccine is more cost effective than old vaccine
MDedge Family Medicine
Full report confirms solanezumab’s failure to rescue cognition in mild Alzheimer’s
MDedge Family Medicine
Elderly trauma patients at high risk for post-discharge mortality
MDedge Family Medicine
APOE4 may drive tau deposition in Alzheimer’s
MDedge Family Medicine
Elderly at highest CV risk get short-statined
MDedge Family Medicine